Interstitial lung diseases
Oral presentation
ILDs: From bench to bedside
Methods :
Cell and molecular biology, Epidemiology, Imaging, Endoscopy and interventional pulmonology, General respiratory patient care
08:30
Late Breaking Abstract - Loss of PTEN induces alveolar epithelial cell senescence resulting in lung fibrosis via activated NF-?B
Y. Tian(Nanjing, China)
COI
2
08:45
Late Breaking Abstract - Mesenchymal stromal cell exosomes prevent and revert experimental pulmonary fibrosis through systemic modulation of monocyte phenotypes
N. Mansouri(Lausanne, Switzerland)
COI
3
09:00
Late Breaking Abstract - A Deep Learning Algorithm for Classifying Fibrotic Lung Disease on High Resolution Computed Tomography
S. Walsh(London, United Kingdom)
COI
4
09:15
Late Breaking Abstract - Idiopathic Pulmonary Fibrosis – a worldwide review of ‘real’ life’ practice: experience from a treatment feasibility review in 41 countries
M. Wijsenbeek(Rotterdam, Netherlands)
COI
5
09:30
Late Breaking Abstract - Ten years experience of whole lung lavage for PAP cases in Songklanagarind hospital
P. Kaenmuang(Songkhla, Thailand)
COI
6
09:45
Late Breaking Abstract - Prognostic analysis of secondary pulmonary alveolar proteinosis: Inspection by one of the world’s largest data.
H. Ishii(Tokyo, Japan)
COI
7
10:00
Late Breaking Abstract - Phase 1 dose escalation study of aerosolized pirfenidone in normal healthy volunteers (NHV), smokers, and IPF patients
A. Montgomery(Seatle, United States)
COI
8
. . .
